The 12th AFMC International Medicinal Chemistry Symposium (AIMECS 2019) in Istanbul, Turkey

AFMC‐AIMECS meetings are internationally organized biannually by the Asian Federation for Medicinal Chemistry (AFMC) and are focused on recent studies in drug discovery and development both in academia and industry. Member organizations of the AFMC are the Pharmaceutical Society of Japan, the Chinese Pharmaceutical Association, the Royal Australian Chemical Institute, the Pharmaceutical Society of Korea, the Korean Chemical Society, the Chemical Society Located in Taipei, the Indonesian Society of Medicinal Chemistry, the Medicinal Chemistry Section of the Israel Chemical Society, and the Computer‐Aided Drug Design & Development Society in Turkey. Each time, the symposium is organized within these member countries. The AIMECS 2019 symposium was held in Turkey this year, as Prof. Dr. Esin Aki‐Yalcin is the current president of the AFMC (2018–2020); the next AIMECS meeting will be organized in 2021 in Tokyo, Japan. In this report, we discuss key topics at the 12th AFMC International Medicinal Chemistry Symposium — New Avenues for Design and Development of Translational Medicine (AIMECS 2019) held in Istanbul, September 8–11, 2019. Bosporus strait talking: AFMC‐AIMECS meetings are internationally organized biannually by the Asian Federation for Medicinal Chemistry (AFMC) and are focused on recent studies in drug discovery and development both in academia and industry. This report discusses highlights of the 12th Asian Federation for Medicinal Chemistry (AFMC) International Medicinal Chemistry Symposium (AIMECS 2019), held September 8–11, 2019, in Istanbul, Turkey.